摘要
目的:为提升我国医药产业经济效益提供参考。方法:基于江苏省泰州、连云港等11个地级市2011年统计年鉴中医药产业的相关数据,构建医药产业经济效益评估因子体系;并基于因子分析理论,分析这11个地级市产业经济效益的综合得分及影响因素,提出提高产业经济效益的政策建议。结果与结论:医药产业经济效益评估因子包括所有者权益、工业总产值、产品销售收入等,影响经济效益的主要因素包括规模水平、盈利水平和资产运营能力3个公因子。3个公因子对11个地级市的经济效益评价情况与现状基本吻合,其中规模水平是差异性的决定性因素。提升我国医药产业经济效益水平的关键措施在于提高产业规模水平和促进区域差异化优势。
OBJECTIVE：To provide reference for the improvement of economic benefit of pharmaceutical industries in China.METHODS：An evaluation index system of economic benefit for pharmaceutical industries had been established,based on relevant data of pharmaceutical industries in 2011 statistical yearbook of 11 prefecture-level cities in Jiangsu province,such as Taizhou,Lianyungang,etc.Based on the theory of factor analysis,comprehensive score and influential factors of economic benefit of pharmaceutical industries in prefecture-level cities,and policies and suggestions for the improvement of pharmaceutical industries were put forward.RESULTS CONCLUSIONS：The evaluation indexes of economic benefit for pharmaceutical industries include owner＇s equity,gross industrial output value,sales income,etc.Main influential factors contain 3 common factors,i.e.scale,profit level and asset operational capability.The evaluation of economic benefit in 11 prefecture-level cities is almost consistent with the situation,based on 3 common factors.The scale and level of industry are determining factor of benefit difference.The key measures to increase the economic benefit of pharmaceutical industries are enlarging the scale of pharmaceutical industries and developing the regional differences advantages.
出处
《中国药房》
CAS
CSCD
2013年第13期1153-1156,共4页
China Pharmacy
关键词
医药产业
经济效益
差异性分析
因子分析法
规模水平
区域差异化优势
Pharmaceutical industries
Economic benefit
Differences analysis
Factor analysis
Scale and level
Regional differences advantages
